The global influenza vaccines market is anticipated to witness significant growth from 2019 to 2025, driven by factors such as increasing prevalence of influenza, growing awareness about vaccination, and rising government initiatives to promote vaccination programs. The market is segmented by vaccine type, technology, and end-user.

Based on vaccine type, the market is segmented into trivalent influenza vaccines and quadrivalent influenza vaccines. The quadrivalent influenza vaccines segment is expected to witness significant growth over the forecast period, owing to the increasing demand for vaccines that can protect against four different influenza viruses.

Based on technology, the Influenza Vaccines Market is segmented into egg-based vaccines, cell culture-based vaccines, and recombinant-based vaccines. The cell culture-based vaccines segment is expected to witness significant growth over the forecast period, owing to the advantages of cell culture-based vaccines over egg-based vaccines.

North America dominated the market in 2019, owing to the high prevalence of influenza, increasing government initiatives to promote vaccination programs, and presence of key market players in the region. Some of the key players operating in the market include GlaxoSmithKline plc, Sanofi S.A., Pfizer, Inc., Novart.

Read more @ https://influentialblogging.blogspot.com/2023/04/global-influenza-vaccines-market-is.html